Antisense and siRNA as agonists of Toll-like receptors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-12-06

AUTHORS

Sudhir Agrawal, Ekambar R Kandimalla

ABSTRACT

About 25 years ago, researchers first demonstrated that a short synthetic oligodeoxynucleotide, referred to as antisense, can inhibit replication of Rous sarcoma virus through hybridization to viral RNA. Since then, several hybridization-based oligonucleotide approaches have been developed to elucidate the functions of genes and their potential as therapeutic agents. Short-interfering (si) RNA is the most recent example. To effectively inhibit gene expression, an antisense or siRNA must be resistant to nucleases, be taken up efficiently by cells, hybridize efficiently with the target mRNA and activate selective degradation of the target mRNA or block its translation without causing undesirable side effects. However, both antisense and siRNA agents have been shown to exert non-target-related biological effects including immune stimulation. Do antisense and siRNA agents work as ligands for Toll-like receptors (TLRs), a family of pathogen-associated, molecular pattern recognition receptors? More... »

PAGES

1533-1537

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/nbt1042

DOI

http://dx.doi.org/10.1038/nbt1042

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1017798045

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15583662


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Silencing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Targeting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Glycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Antisense", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Small Interfering", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Cell Surface", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Toll-Like Receptors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hybridon, Inc., 345 Vassar Street, 02139, Cambridge, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.452508.e", 
          "name": [
            "Hybridon, Inc., 345 Vassar Street, 02139, Cambridge, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Agrawal", 
        "givenName": "Sudhir", 
        "id": "sg:person.01124454740.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hybridon, Inc., 345 Vassar Street, 02139, Cambridge, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.452508.e", 
          "name": [
            "Hybridon, Inc., 345 Vassar Street, 02139, Cambridge, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kandimalla", 
        "givenName": "Ekambar R", 
        "id": "sg:person.0772330367.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772330367.88"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nri1329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032165765", 
          "https://doi.org/10.1038/nri1329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd1345", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036558483", 
          "https://doi.org/10.1038/nrd1345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng1173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000001349", 
          "https://doi.org/10.1038/ng1173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncb1038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020695123", 
          "https://doi.org/10.1038/ncb1038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/rr153", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031048536", 
          "https://doi.org/10.1186/rr153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3300880", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052055118", 
          "https://doi.org/10.1038/sj.gt.3300880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt0704-788", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023323564", 
          "https://doi.org/10.1038/nbt0704-788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt831", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021890587", 
          "https://doi.org/10.1038/nbt831"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01709367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053069996", 
          "https://doi.org/10.1007/bf01709367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35099560", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031094923", 
          "https://doi.org/10.1038/35099560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35047123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001385025", 
          "https://doi.org/10.1038/35047123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2172-4-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043825279", 
          "https://doi.org/10.1186/1471-2172-4-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-12-06", 
    "datePublishedReg": "2004-12-06", 
    "description": "About 25 years ago, researchers first demonstrated that a short synthetic oligodeoxynucleotide, referred to as antisense, can inhibit replication of Rous sarcoma virus through hybridization to viral RNA. Since then, several hybridization-based oligonucleotide approaches have been developed to elucidate the functions of genes and their potential as therapeutic agents. Short-interfering (si) RNA is the most recent example. To effectively inhibit gene expression, an antisense or siRNA must be resistant to nucleases, be taken up efficiently by cells, hybridize efficiently with the target mRNA and activate selective degradation of the target mRNA or block its translation without causing undesirable side effects. However, both antisense and siRNA agents have been shown to exert non-target-related biological effects including immune stimulation. Do antisense and siRNA agents work as ligands for Toll-like receptors (TLRs), a family of pathogen-associated, molecular pattern recognition receptors?", 
    "genre": "article", 
    "id": "sg:pub.10.1038/nbt1042", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1115214", 
        "issn": [
          "1087-0156", 
          "1546-1696"
        ], 
        "name": "Nature Biotechnology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "Toll-like receptors", 
      "molecular pattern recognition receptors", 
      "pattern recognition receptors", 
      "undesirable side effects", 
      "immune stimulation", 
      "side effects", 
      "recognition receptors", 
      "therapeutic agents", 
      "short-interfering RNA", 
      "viral RNA", 
      "receptors", 
      "siRNA agents", 
      "biological effects", 
      "synthetic oligodeoxynucleotides", 
      "siRNA", 
      "Rous sarcoma virus", 
      "short synthetic oligodeoxynucleotides", 
      "antisense", 
      "sarcoma virus", 
      "gene expression", 
      "agents", 
      "mRNA", 
      "oligonucleotide approach", 
      "target mRNAs", 
      "agonists", 
      "RNA", 
      "stimulation", 
      "virus", 
      "effect", 
      "cells", 
      "expression", 
      "years", 
      "oligodeoxynucleotides", 
      "replication", 
      "genes", 
      "function of genes", 
      "hybridization", 
      "family", 
      "function", 
      "potential", 
      "selective degradation", 
      "ligands", 
      "translation", 
      "recent examples", 
      "nuclease", 
      "approach", 
      "degradation", 
      "researchers", 
      "example"
    ], 
    "name": "Antisense and siRNA as agonists of Toll-like receptors", 
    "pagination": "1533-1537", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1017798045"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/nbt1042"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15583662"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/nbt1042", 
      "https://app.dimensions.ai/details/publication/pub.1017798045"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_378.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/nbt1042"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nbt1042'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nbt1042'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nbt1042'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nbt1042'


 

This table displays all metadata directly associated to this object as RDF triples.

205 TRIPLES      21 PREDICATES      96 URIs      76 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/nbt1042 schema:about N12f22199e9614886aad9d21a33bb18f0
2 N28574b7f21aa42709b4fed5162476817
3 N337159ef14934c02891db0a6c98ad281
4 N554cd85b398646c0b7da6add0baf897b
5 N9365be31b2694c18a3a1971b429dafbc
6 Na3bd85cbce4744fc9b2e238a39ed2cad
7 Nac93ddfbc07a4d4392ed8e03a83fda9e
8 Nbe0e6cdf35f6405481947e1ed5a215e8
9 Nc889cee923e143f99524ed60afe22e31
10 Nffb685a6c25b463bb10bb1856bb69412
11 anzsrc-for:11
12 anzsrc-for:1108
13 schema:author N0db7049fd3054e47a2ea00c7f359cc35
14 schema:citation sg:pub.10.1007/bf01709367
15 sg:pub.10.1038/35047123
16 sg:pub.10.1038/35099560
17 sg:pub.10.1038/nbt0704-788
18 sg:pub.10.1038/nbt831
19 sg:pub.10.1038/ncb1038
20 sg:pub.10.1038/ng1173
21 sg:pub.10.1038/nrd1345
22 sg:pub.10.1038/nri1329
23 sg:pub.10.1038/sj.gt.3300880
24 sg:pub.10.1186/1471-2172-4-8
25 sg:pub.10.1186/rr153
26 schema:datePublished 2004-12-06
27 schema:datePublishedReg 2004-12-06
28 schema:description About 25 years ago, researchers first demonstrated that a short synthetic oligodeoxynucleotide, referred to as antisense, can inhibit replication of Rous sarcoma virus through hybridization to viral RNA. Since then, several hybridization-based oligonucleotide approaches have been developed to elucidate the functions of genes and their potential as therapeutic agents. Short-interfering (si) RNA is the most recent example. To effectively inhibit gene expression, an antisense or siRNA must be resistant to nucleases, be taken up efficiently by cells, hybridize efficiently with the target mRNA and activate selective degradation of the target mRNA or block its translation without causing undesirable side effects. However, both antisense and siRNA agents have been shown to exert non-target-related biological effects including immune stimulation. Do antisense and siRNA agents work as ligands for Toll-like receptors (TLRs), a family of pathogen-associated, molecular pattern recognition receptors?
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf Nf655e404917a4a8999de5c34ab75fe2e
32 Nfb37367d04694ddf956c4a37a2e07423
33 sg:journal.1115214
34 schema:keywords RNA
35 Rous sarcoma virus
36 Toll-like receptors
37 agents
38 agonists
39 antisense
40 approach
41 biological effects
42 cells
43 degradation
44 effect
45 example
46 expression
47 family
48 function
49 function of genes
50 gene expression
51 genes
52 hybridization
53 immune stimulation
54 ligands
55 mRNA
56 molecular pattern recognition receptors
57 nuclease
58 oligodeoxynucleotides
59 oligonucleotide approach
60 pattern recognition receptors
61 potential
62 recent examples
63 receptors
64 recognition receptors
65 replication
66 researchers
67 sarcoma virus
68 selective degradation
69 short synthetic oligodeoxynucleotides
70 short-interfering RNA
71 siRNA
72 siRNA agents
73 side effects
74 stimulation
75 synthetic oligodeoxynucleotides
76 target mRNAs
77 therapeutic agents
78 translation
79 undesirable side effects
80 viral RNA
81 virus
82 years
83 schema:name Antisense and siRNA as agonists of Toll-like receptors
84 schema:pagination 1533-1537
85 schema:productId N29d5c9d02aca48219ffc1f178c3f0fd5
86 N56bb63ca0d1f4d73aa9f3b918a4f8e48
87 Nfcfb7af670a7420e8be73471b432ce25
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017798045
89 https://doi.org/10.1038/nbt1042
90 schema:sdDatePublished 2022-12-01T06:24
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher Nb6c55233b8194178901164e51c6234d5
93 schema:url https://doi.org/10.1038/nbt1042
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N0db7049fd3054e47a2ea00c7f359cc35 rdf:first sg:person.01124454740.04
98 rdf:rest N86830c279fd44a1580e3e043e8a4e2b8
99 N12f22199e9614886aad9d21a33bb18f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Genetic Therapy
101 rdf:type schema:DefinedTerm
102 N28574b7f21aa42709b4fed5162476817 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N29d5c9d02aca48219ffc1f178c3f0fd5 schema:name doi
106 schema:value 10.1038/nbt1042
107 rdf:type schema:PropertyValue
108 N337159ef14934c02891db0a6c98ad281 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name RNA, Small Interfering
110 rdf:type schema:DefinedTerm
111 N554cd85b398646c0b7da6add0baf897b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name RNA, Antisense
113 rdf:type schema:DefinedTerm
114 N56bb63ca0d1f4d73aa9f3b918a4f8e48 schema:name dimensions_id
115 schema:value pub.1017798045
116 rdf:type schema:PropertyValue
117 N86830c279fd44a1580e3e043e8a4e2b8 rdf:first sg:person.0772330367.88
118 rdf:rest rdf:nil
119 N9365be31b2694c18a3a1971b429dafbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Toll-Like Receptors
121 rdf:type schema:DefinedTerm
122 Na3bd85cbce4744fc9b2e238a39ed2cad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Clinical Trials as Topic
124 rdf:type schema:DefinedTerm
125 Nac93ddfbc07a4d4392ed8e03a83fda9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Receptors, Cell Surface
127 rdf:type schema:DefinedTerm
128 Nb6c55233b8194178901164e51c6234d5 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 Nbe0e6cdf35f6405481947e1ed5a215e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Membrane Glycoproteins
132 rdf:type schema:DefinedTerm
133 Nc889cee923e143f99524ed60afe22e31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Gene Silencing
135 rdf:type schema:DefinedTerm
136 Nf655e404917a4a8999de5c34ab75fe2e schema:volumeNumber 22
137 rdf:type schema:PublicationVolume
138 Nfb37367d04694ddf956c4a37a2e07423 schema:issueNumber 12
139 rdf:type schema:PublicationIssue
140 Nfcfb7af670a7420e8be73471b432ce25 schema:name pubmed_id
141 schema:value 15583662
142 rdf:type schema:PropertyValue
143 Nffb685a6c25b463bb10bb1856bb69412 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Gene Targeting
145 rdf:type schema:DefinedTerm
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
150 schema:name Medical Microbiology
151 rdf:type schema:DefinedTerm
152 sg:journal.1115214 schema:issn 1087-0156
153 1546-1696
154 schema:name Nature Biotechnology
155 schema:publisher Springer Nature
156 rdf:type schema:Periodical
157 sg:person.01124454740.04 schema:affiliation grid-institutes:grid.452508.e
158 schema:familyName Agrawal
159 schema:givenName Sudhir
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04
161 rdf:type schema:Person
162 sg:person.0772330367.88 schema:affiliation grid-institutes:grid.452508.e
163 schema:familyName Kandimalla
164 schema:givenName Ekambar R
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772330367.88
166 rdf:type schema:Person
167 sg:pub.10.1007/bf01709367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053069996
168 https://doi.org/10.1007/bf01709367
169 rdf:type schema:CreativeWork
170 sg:pub.10.1038/35047123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001385025
171 https://doi.org/10.1038/35047123
172 rdf:type schema:CreativeWork
173 sg:pub.10.1038/35099560 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031094923
174 https://doi.org/10.1038/35099560
175 rdf:type schema:CreativeWork
176 sg:pub.10.1038/nbt0704-788 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023323564
177 https://doi.org/10.1038/nbt0704-788
178 rdf:type schema:CreativeWork
179 sg:pub.10.1038/nbt831 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021890587
180 https://doi.org/10.1038/nbt831
181 rdf:type schema:CreativeWork
182 sg:pub.10.1038/ncb1038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020695123
183 https://doi.org/10.1038/ncb1038
184 rdf:type schema:CreativeWork
185 sg:pub.10.1038/ng1173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000001349
186 https://doi.org/10.1038/ng1173
187 rdf:type schema:CreativeWork
188 sg:pub.10.1038/nrd1345 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036558483
189 https://doi.org/10.1038/nrd1345
190 rdf:type schema:CreativeWork
191 sg:pub.10.1038/nri1329 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032165765
192 https://doi.org/10.1038/nri1329
193 rdf:type schema:CreativeWork
194 sg:pub.10.1038/sj.gt.3300880 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052055118
195 https://doi.org/10.1038/sj.gt.3300880
196 rdf:type schema:CreativeWork
197 sg:pub.10.1186/1471-2172-4-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043825279
198 https://doi.org/10.1186/1471-2172-4-8
199 rdf:type schema:CreativeWork
200 sg:pub.10.1186/rr153 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031048536
201 https://doi.org/10.1186/rr153
202 rdf:type schema:CreativeWork
203 grid-institutes:grid.452508.e schema:alternateName Hybridon, Inc., 345 Vassar Street, 02139, Cambridge, Massachusetts, USA
204 schema:name Hybridon, Inc., 345 Vassar Street, 02139, Cambridge, Massachusetts, USA
205 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...